Navigation Links
Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
Date:2/6/2008

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, planned clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of preclinical studies or clinical trials may not be predictive of future results, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents, and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Contacts: Jack Lief Mary Claire Duch

President and CEO WeissComm Partners

Media Relations

David Walsey 212.301.7228

Director, Corporate Communications


'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
2. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
3. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
4. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
5. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
7. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
8. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
10. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
11. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... right amount of tension to a chain of carbon ... an insulator, according to Rice University scientists. , Stretching ... chain of carbon atoms -- by just 3 percent ... engineers might find useful for mechanically activated nanoscale electronics ... Boris Yakobson and his colleagues appears in the American ...
(Date:7/21/2014)... (July 21, 2014) The yield so far is ... developed a low-energy, solution-based mineral substitution process to make ... use in electronics and alternative energy devices. , A ... of the July 21 issue of the journal ... research in the inorganic and nuclear chemistry fields. The ...
(Date:7/21/2014)... York , July 21, 2014 ... on Global & USA ... Trends, and Forecasts ResearchMoz presents this ... Biomaker Market   to 2018 (Identification, Technologies, Market Analysis, ... Trends, and Pipeline Analysis. GLOBAL & ...
(Date:7/20/2014)... nuclear fuel gets recycled, the process releases radioactive krypton ... basements with the related gas radon. A new porous ... appearing July 20 in Nature Materials shows ... but not out. , The CC3 material could ... from nuclear fuel or air in buildings and also ...
Breaking Biology Technology:Carbyne morphs when stretched 2Carbyne morphs when stretched 3Oregon chemists eye improved thin films with metal substitution 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6A noble gas cage 2A noble gas cage 3
... Mass., Oct. 21 Myriant Technologies LLC (Myriant), ... biochemicals, announced the formation of its Science Advisory ... Board members individually and collectively will provide broad ... business of converting renewable biomass feedstocks into valuable ...
... Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty ... products primarily for the respiratory and related markets, today ... 8:30 AM ET on Wednesday, November 4, 2009, to ... 30, 2009. Management will also provide an update ...
... ... investors, interest. , ... Miami, FL (PRWEB) October 21, 2009 -- iLife Americas, LLC, a leading developer and ... to market its line of iLife wellness and therapeutic products. Officially opened on September ...
Cached Biology Technology:Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 2Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 3Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call 2Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call 3iLife Americas, LLC Enters U.S. Wellness and Therapeutic Markets 2
(Date:7/22/2014)... squirrels have adapted to New York City,s human behaviour, ... better, than their fellow squirrels in the woods. , ... Environment & Agriculture, led the study that proved eastern ... urban environments and prevent unnecessary responses when humans acted ... footpath. , "As we rapidly increase the spread ...
(Date:7/22/2014)... darker side of meerkats which sees them prevent their ... in a new study. , Research into the desert creatures ... and many adult helpers shows that the alpha female ... , The study shows how this way of life, also ... prove effective despite its sinister side. , Dominant meerkats ...
(Date:7/21/2014)... researchers have detected genetic fragments of Middle East Respiratory ... holding a camel infected with the virus. The work, ... open-access journal of the American Society for Microbiology, indicates ... disease can be transmitted through the air. , MERS, ... has been identified in 699 people as of June ...
Breaking Biology News(10 mins):New York squirrels are nuts about city life 2Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2
... Spanish . , Studying living things can ... by a specific environment. A research team from the ... Etxebarria as director, is involved in this monitoring of ... ports are contaminated; what we are investigating is to ...
... vertebrates with separate sexes, sex determination can be genotypic ... reptiles, where the ambient temperature during sensitive periods of ... male or female. The number of males and females ... demographic parameter crucial for population viability. A number ...
... Mellon University,s Christopher L. Weber argues that China,s new ... at least partly due to consumption of Chinese goods ... prepare to participate in the 2008 Olympic Games in ... the growing pollution caused by smoke and smog from ...
Cached Biology News:Mussels to determine how much contamination is in the ports 2Mussels to determine how much contamination is in the ports 3Fish with temperature-dependent sex determination face global warming 2Carnegie Mellon Researcher says China's export trade impacts climate 2
... Dithiothreitol DTT White ... Purity: ≥99% by titration. ... Absorbance: (100 mM, 280 ... EtOH or H 2 O. ...
... more user-friendliness and absolute reliability united within ... of the Mastercycler ep system. In the ... been developing dynamically. The same applies to ... To keep pace with these technological advances, ...
... is designed for easy transformation of the ... for successful transformation simply by mixing a ... cultured yeast cells. No complicated steps, such ... The kit is particularly well suited for ...
... light balance makes your life easier. It offers a ... management for one balance. *Instruments supported: ... MX, UMX, AG, XS, XP, PR, SR, PG-S, PG, ... management: User guidance ...
Biology Products: